摘要
目的:靶向沉默人乳腺癌细胞Survivin与雌激素受体-α(ER-α)36双基因的表达,探讨其对乳腺癌MDA-MB-231细胞增殖与凋亡的影响。方法:采用生物信息学技术设计并构建RNAi片段(siRNA-ER-α36),转染乳腺癌MDA-MB-231细胞株。采用噻唑蓝染色法检测细胞增殖情况。采用RT-PCR、Western blot方法检测细胞中Survivin、ER-α36与凋亡蛋白Caspase-3的mRNA及蛋白表达情况;流式细胞术检测转染细胞凋亡率。结果:RNAi片段成功转染MDA-MB-231细胞,24 h转染率的平均值为68%,48 h转染效率可达76%(P<0.01)。与空白对照组比较,RNAi片段转染后MDA-MB-231细胞Survivin和ER-α36基因的mRNA和蛋白含量明显下降(P<0.05),而上调Caspase-3凋亡蛋白的表达;MDA-MB-231细胞增殖能力降低(P<0.05),凋亡率升高(P<0.05)。结论:RNAi靶向沉默并下调Survivin与ER-α36基因的表达,上调Caspase-3凋亡蛋白的表达,从而抑制乳腺癌MDA-MB-231细胞增殖,促进细胞凋亡,提示RNAi沉默可成为对乳腺癌相关基因功能研究的主要技术之一。
Objective:To explore the effect of RNA interference on human breast cancer MDA-MB-231 cell proliferation and apoptosis by inhibiting Survivin and ER-α36 double expression.Methods:RNAi fragment(siRNA-ER-α36)was designed and constructed by bioinformatics technology and transfected into breast cancer MDA-MB-231 cell line.Cell proliferation was detected by thiazol blue staining.RT-PCR and Western blot were used to detect the mRNA and protein expression of Survivin,ER-α36 and apoptosis protein Caspase-3.The apoptosis rate of transfected cells was detected by flow cytometry.Results:RNAi fragments were successfully transfected into MDA-MB-231 cells,the average transfection rate of 24 h was 68%,and the transfection efficiency of 48 h was 76%(P<0.01).Compared with the blank control group,the mRNA and protein contents of Survivin and ER-α36 genes in MDA-MB-231 cells transfected with RNAi fragment were significantly decreased(P<0.05),while the expression of Caspase-3 apoptosis protein was up-regulated.The proliferation ability of MDA-MB-231 cells was decreased(P<0.05),and the apoptosis rate was increased(P<0.05).Conclusion:RNAi targeted silencs and down-regulats the expression of Survivin and ER-α36 genes,up-regulats the expression of Caspase-3 apoptosis protein,thereby inhibits the proliferation of breast cancer MDA-MB-231 cells and promots cell apoptosis,suggesting that RNAi silencing can become one of the main technologies for the study of breast cancer related gene function.
作者
高爽
罗钫月
高鸿霞
杨巍
GAO Shuang;LUO Fangyue;GAO Hongxia;YANG Wei(School of Laboratory Medicine,Beihua University,Jilin 132013,China)
出处
《中国免疫学杂志》
CAS
CSCD
北大核心
2023年第5期933-938,共6页
Chinese Journal of Immunology
基金
吉林省卫生技术创新项目(2017J087)
吉林省卫生计生青年科技骨干培养计划项目(2017Q039)。